Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Faulds

Showing results (51-60 of 118) with videos related to

Pageof 12
Sort By:
Drugs|May 1, 1992
Intranasal fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitisH M Bryson, D Faulds
Drugs|September 13, 2000
EsomeprazoleC M Spencer, D Faulds
Pharmacoeconomics|May 8, 1995
Salmeterol. An appraisal of its quality-of-life benefits and potential pharmacoeconomic positioning in asthmaD H Peters, D Faulds
Pharmacoeconomics|January 8, 1994
Hepatitis B vaccine: a pharmacoeconomic evaluation of its use in the prevention of hepatitis B virus infectionS M Holliday, D Faulds
Drugs|February 1, 1996
Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disordersL R Wiseman, D Faulds
Drugs|August 1, 1996
Nisoldipine coat-core. A review of its pharmacology and therapeutic efficacy in hypertensionG L Plosker, D Faulds
Drugs|April 1, 1994
Parnaparin. A review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disordersJ E Frampton, D Faulds
Drugs & Aging|April 1, 1995
Goserelin. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in prostate cancerR N Brogden, D Faulds
Drugs & Aging|July 1, 1994
Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancerL B Barradell, D Faulds
Drugs|May 1, 1993
Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapyG L Plosker, D Faulds
Pageof 12

Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
Drugs|May 1, 1992
Intranasal fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitisH M Bryson, D Faulds
Drugs|September 13, 2000
EsomeprazoleC M Spencer, D Faulds
Pharmacoeconomics|May 8, 1995
Salmeterol. An appraisal of its quality-of-life benefits and potential pharmacoeconomic positioning in asthmaD H Peters, D Faulds
Pharmacoeconomics|January 8, 1994
Hepatitis B vaccine: a pharmacoeconomic evaluation of its use in the prevention of hepatitis B virus infectionS M Holliday, D Faulds
Drugs|February 1, 1996
Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disordersL R Wiseman, D Faulds
Drugs|August 1, 1996
Nisoldipine coat-core. A review of its pharmacology and therapeutic efficacy in hypertensionG L Plosker, D Faulds
Drugs|April 1, 1994
Parnaparin. A review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disordersJ E Frampton, D Faulds
Drugs & Aging|April 1, 1995
Goserelin. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in prostate cancerR N Brogden, D Faulds
Drugs & Aging|July 1, 1994
Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancerL B Barradell, D Faulds
Drugs|May 1, 1993
Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapyG L Plosker, D Faulds
Pageof 12